4//SEC Filing
Kumar Neil 4
Accession 0001470831-25-000353
CIK 0001743881other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 7:31 PM ET
Size
18.2 KB
Accession
0001470831-25-000353
Insider Transaction Report
Form 4
Kumar Neil
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2025-11-16$66.39/sh−32,855$2,181,243→ 254,932 total - Exercise/Conversion
Restricted Stock Units
2025-11-16−33,544→ 167,720 total→ Common Stock (33,544 underlying) - Exercise/Conversion
Common Stock
2025-11-16+33,544→ 256,634 total - Exercise/Conversion
Common Stock
2025-11-16+19,599→ 276,233 total - Exercise/Conversion
Restricted Stock Units
2025-11-16−19,599→ 176,394 total→ Common Stock (19,599 underlying) - Exercise/Conversion
Common Stock
2025-11-16+11,554→ 287,787 total - Exercise/Conversion
Restricted Stock Units
2025-11-16−11,554→ 150,199 total→ Common Stock (11,554 underlying)
Holdings
- 795,686(indirect: By Trust)
Common Stock
- 4,598,447(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 64,697 shares of Common Stock underlying the Reporting Person's RSUs.
- [F3]The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
- [F4]The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
- [F5]The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
- [F6]The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2025. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001742485
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 7:31 PM ET
- Size
- 18.2 KB